| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 185.43B | 185.11B | 183.59B | 160.74B | 151.55B | 182.02B |
| Gross Profit | 16.27B | 14.86B | 11.93B | 11.97B | 15.11B | 15.79B |
| EBITDA | 5.76B | 6.79B | 7.55B | 4.84B | 7.32B | 7.57B |
| Net Income | 2.63B | 3.43B | 4.26B | 2.36B | 4.71B | 4.39B |
Balance Sheet | ||||||
| Total Assets | 241.01B | 225.10B | 211.27B | 183.40B | 173.08B | 185.24B |
| Cash, Cash Equivalents and Short-Term Investments | 16.93B | 16.53B | 18.61B | 17.19B | 19.30B | 17.95B |
| Total Debt | 82.25B | 56.00B | 34.33B | 30.10B | 29.05B | 30.23B |
| Total Liabilities | 169.53B | 154.98B | 139.14B | 117.85B | 109.14B | 122.19B |
| Stockholders Equity | 71.15B | 69.81B | 71.83B | 65.08B | 63.47B | 62.59B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -20.77B | -4.29B | -721.00M | 5.12B | 4.15B |
| Operating Cash Flow | 0.00 | -20.29B | 3.97B | -219.00M | 5.27B | 4.23B |
| Investing Cash Flow | 0.00 | 615.00M | -4.29B | -2.49B | -810.00M | -1.72B |
| Financing Cash Flow | 0.00 | 17.93B | 1.15B | 580.00M | -3.43B | -3.71B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥81.67B | 11.48 | ― | 3.64% | 18.01% | 15.27% | |
74 Outperform | ¥80.64B | 12.33 | ― | 3.55% | 8.02% | 64.54% | |
73 Outperform | ¥89.71B | 12.54 | ― | 1.25% | 2.61% | -13.38% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥69.41B | 7.46 | ― | 3.84% | -8.79% | ― | |
62 Neutral | ¥88.76B | 12.57 | ― | 8.02% | 2.51% | 4.02% | |
48 Neutral | ¥74.02B | -149.33 | ― | 2.73% | -3.59% | 49.34% |